You are here

Home » Content

Reprodüktif çağdaki kadınlarda toksoplazmozis seroprevalansı

Seroprevalance Of Toxoplasmosis In Reproductive Women

Journal Name:

  • Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2008

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Toxoplasmosis is a parasitic disease caused by a protozoon, Toxoplasma gondii. Infection, acquired during pregnancy may cause intrauterine damage and sequelae in the newborn. Therefore toxoplasmosis must be searched in reproductive women. We aimed to investigate toxoplasmosis seroprevalance in 433 patients (18¬49 age group) attending the Obstetric & Gynecology clinic and policlinic of Suleyman Demirel University Researching and Application Hospital between August 2005-July 2006. We separated patients to three groups: 18-25, 26-35 and 365 age groups. IgG positivities were respectively 21.3 %, 26.1% and 28.2%; IgM positivities were respectively 0 %, 2.5 % and 7.3 %.%. IgG avidity results detected from 2 patients in 26-35 age group was high. In conclusion, the importance of searching the seroprevalance of toxoplasmosis, which is still considered as an important health problem in reproductive women, must be emphasized.
Bookmark/Search this post with
Abstract (Original Language): 
Toksoplazmozis, Toxoplasma gondü'nin sebep olduğu parazitik bir hastalıktır. Gebelik esnasında alınan infeksiyon yenidoğanda intrauterin hasar ve sekellere sebep olabilir. Bu nedenle reprodüktif dönemdeki kadınlarda toksoplazmozis araştırılmalıdır. Ağustos 2005-Temmuz 2006 tarihleri arasında Kadın Hastalıkları ve Doğum servis ve polikliniğine başvuran 18-49 yaş grubundaki 433 hastada toksoplazmozis seroprevalansının araştırılması amaçlandı. Hastalar 18-25, 26-35 ve>36 olarak 3 yaş grubuna ayrıldı. Anti toxoplasma IgG pozitiflikleri sırasıyla % 21.3, % 26.1 ve % 28.2; anti toxoplasma IgM değerleri ise % 0, % 2.5 ve % 7.3 olarak tespit edildi. 26-35 yaş grubunda bulunan 2 hastada anti toxoplasma IgG avidite değerleri yüksek olarak değerlendirildi. Sonuç olarak, günümüzde reprodüktif dönemdeki kadınlar için halen önemli bir sağlık problemi olarak yerini koruyan toksoplazmozisin seroprevalansının araştırılmasının önemi vurgulanmalıdır.
FULL TEXT (PDF): 
PDF icon arastirmax-reproduktif-cagdaki-kadinlarda-toksoplazmozis-seroprevalansi.pdf
  • 2
21-24
  • Turkish

REFERENCES

References: 

1. Kapperud G, Jenum PA, Stray-Pedersen B, Melby KK, Eskild A, Eng J. Risk factors for Toxoplasma gondii infection in pregnancy .Results ofaprospective case-control study in Norway Am J Epidemiol 1996; 144:405-12.
2. Lynfield R, Guerina NG. Toksoplasmosis Pediatrics inReview. 1997; 18(3): 75-84.
3. Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Aufrant C, Valenti D, and Cox WL. Prenatal management of 746 pregnancies at risk for congenital Toksoplasmosis. N Engl J Med 1988; 318:271-275
4. Hohlfeld P, Daffos F, Thulliez P, Aufrant C, Couvreur J, MacAleese J et al Fetal Toksoplasmosis: outcome ofpregnancy and infant follow-up after in utero treatment. J. Pediatr. 1989; 115:765-769.
5. Remington, JS, McLeod R, and Desmonts G. Toksoplasmosis, p.140-267. In J. S. Remington and J. O. Klein (ed.), Infectious diseases ofthe fetus and newborn infant, 4th ed. 1995; The W. B. Saunders
Company, Philadelphia Pa.
6. Esquivel CA, Sethi S, Janitschke K, Hahn H, Liesenfeld O. Comparison oftwo commercialy available avidity tests for Toxoplasma-specific IgG antibodies. Arch MedRes 2002; 33:520-523.
7. Jenum PA, Stray-Pedersen B, Melby KK, Kapperud G, Whitelaw A, Eskild A et al. Incidence ofT. gondii infection in pregnant women. JClin Microbiol 1998; 36: 2907-13.
8. Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS. Effect oftesting for IgG avidity in the diagnosis ofToxoplasma gondii infection in pregnant women. Experience in a US reference laboratory. J InfectDis2001; 183:1248-1253.
9. Prince HE, Wilson M. Simplified assay for measuring Toxoplasma gondii immunoglobulin G avidity. Clin Diagn LabImmunol 2001; 8(5):904-908.
10. Aspock H, Pollak A. Prevention ofprenatal Toksoplasmosis by serological screening ofpregnant women in Austria. Scand J Infect Dis 1992; 84(suppl):
32-7.
11. Montoya JG, Remington JS. Toxoplasma gondii. Mandell, Douglas and Bennett's Principles and Practice ofInfectious Disesases. Fifth edition. Churchill Livingstone 2001;Volume 2, Chapter 268, p.2858-
2888.
12. Foulon W, Naessens A, Volckaert M, Lauwers S, Amy JJ. Congenital Toksoplasmosis: a prospective survey in Brussels. Br. J Obstet Gynaecol 1984; 91: 419-23.
13. Koppe JG, Loewer-Sieger DH, de Roever-Bonnet H. Results of20 year follow-up ofcongenital Toksoplasmosis Lancet 1986; 254-5.
14. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development ofadverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics. 1980; 66: 767-74.
15.
Altınta
ş N, Yolasığmaz A, Yazar S, Şakru N, Kitapcıoğlu G. İzmir ve çevresindeki yerleşim bölgelerinde yaşayan insanlarda Toxoplasma antikorlarının araştırılması. T. Parasitol Derg 1998; 22(3): 229-32.
16.
Kuma
n HA, Altıntaş N, Ak M. Ege bölgesinde Toksoplasmosis rastlanma sıklığı. T. Parasitol Derg 1987; 11: 49-63.
17.
Sütc
ü A, Tuncer İ, Kuru C, Baykan M. Konya ve çevresinde IgG ve IgM prevalansı. T. Parasitol Derg 1998; 1: 3-7.
18.
Yiği
t N, Aktaş AE, Uslu H, Aydın F, Babacan M. Atatürk Üniversitesi Tıp fakültesi Mikrobiyoloji laboratuvarına gelen Toksoplasmosis şüpheli hasta serumlarında Toxoplasma gondi antikorlarının araştırılması. T. Parasitol Derg 2000; 24: 22-24.
19.
Demirc
i M, Arıdoğan BC, Can R ve Kaya S. Isparta'da değişik gruplarda toxoplazmosis seroprevalansı. Türkiye Parazitoloji Dergisi; 2001; 25(2):107-109.
S.D.Ü. Tıp pak. Derg. 2008:15(2)/ 21-24
24
Güneş, Toksoplazmozis seroprevalansı
20. Foudnier F, Chemia CM, Pinon J. Value ofspecific immunglobulin A detection by two immunocapture assays in the diagnosis of Toksoplasmosis. Eur J Microbiol Infect Dis, 1995; 14(7):585-590.
21. Montoya JG, Liesenfeld O, Kinney S, Press C, Remington JS, Vidas test for avidity of Toxoplasma-IgG for confirmatory testing ofpregnant women. J Clin Microbiol, 2002; 40(7):2504-2508.
22. Foudnier F, Chemia CM, Pinon J. Value ofspecific immunglobulin A detection by two immunocapture assays in the diagnosis of Toksoplasmosis. Eur J Microbiol Infect Dis 1995; 14(7):585-590.
23. Logar J, Novak-Antolic Z, Zore A. Improved diagnosis ofToksoplasmosis acquired during pregnancy by determination of specific IgG avidity. IX. International Congres ofParasitology; ICOPAIX Chiba Japan 1998; 1259-1262.
24. Remington JS, Thulliez P, Montoya JG, Minireviev Recent developments for diagnosis ofToksoplasmosis. J Clin Microbiol, 2004; 42(3):941-945.
25. SobieszczanskaB, Przondo-MordarskaA, IgGtoxo avidity in serodiagnosis ofacute Toksoplasmosis. 11th ECCMID İstanbul, Turkey 2001; 1-4 April, P1419.
26. Robert-Gangneux F, Gavinet MF, Ancelle T, Raymond J, Tourte-Schaefer C, Dupouy-Camet J. Value of Prenatal Diagnosis and Early Postnatal Diagnosis of Congenital Toksoplasmosis. Retrospective Study of 110 cases. J Clin Microbiol 1999; 37 (9): 2893-8.

Thank you for copying data from http://www.arastirmax.com